Name
PackGene Biotech INC
What We Do
PackGene Biotech excels as a leader in Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) services, focusing on adeno-associated virus (AAV), mRNA, plasmid DNA, and lentiviral vector (LVV) solutions. Catering to early-stage drug discovery, preclinical development, and cell and gene therapy trials, we offer cost-effective, reliable, and scalable production.

Our π-Alpha 293 AAV High-yield Platform marks a significant leap in AAV production, increasing yields by up to tenfold and supporting large-scale AAV batches up to 1E+17vg, meeting most commercial and clinical project needs.

We also provide scalable, custom plasmid DNA solutions for various project sizes, encompassing end-to-end design, production, and manufacturing. Our GMP plasmid Manufacturing Platform can accommodate production scales from 5L to 200L.

Our services extend to comprehensive process development, analytical development, and cell banking support for AAV, LVV, and plasmid projects.

Additionally, we specialize in mRNA and LNP solutions, supporting the full spectrum of drug and vaccine development from research to GMP production.

Committed to fostering innovation in biotechnology and healthcare, PackGene offers advanced solutions tailored to the evolving demands of the industry.
Founded
2014
Categories (10)
Cell Line Development, Gene Therapy, Plasmids, Vector Manufacturing - RNA, Viral Vector Manufacturing - Adeno-Associated Virus, Viral Vector Manufacturing - Adenovirus, Viral Vector Manufacturing - Lentivirus

Listings

Relevance
mRNA and LNP custom and off-the-shelf products
Lentivirus packaging

Videos

No Data Available